Search Results

You searched for : Janssen

	Wysa's mental health platform raises $20 million Mental health disorders are faced by a wide range of populations across India. But people continue to suffer due to stigma and a lack of ... Jul 15
	HealthQuad Fund-II round closes at $162 million Healthcare venture capital HealthQuad has announced the closing of its second fund round at $162 million.... Apr 01
	Remix Therapeutics enters collaboration with Janssen to advance small molecule therapeutics Latest pharma news update... Feb 21
	Reduced Risk of Long Covid Infection After Vaccination Let us know who has reduced the risk of infection after covid vaccination- Elderly V/s Middle-aged group V/s Young children. Let us ... Feb 18
	Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds Johnson and Johnson vaccine news... Sep 22
	Moderna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC Latest pharma news update... Sep 20
	Johnson & Johnson booster shot prompts large increase in immune response, company says Latest Pharma news update... Aug 26
	J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant, studies find J&J Vaccine gets emergency FDA approval... Jul 06
	Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving J&J vaccine A blood clot is less risky than Covid says CDC... May 13
	WHO authorizes China's Sinopharm Covid-19 vaccine for emergency use Sinopharm is the sixth vaccine to get WHO approval... May 08
	FDA and CDC lift recommend â€œPauseâ€ on Johnson & Johnson Janssen COVID 19 vaccine Safety is a top priority when it comes to vaccines. The pause was an example of extensive safety monitoring for the people and to ensure ... Apr 27
	CDC, FDA deregulates Johnson & Johnson covid vaccine with blood clot warning US lifts ban on the J&J vaccine with a warning on the bottle... Apr 26
	US COVID News Update: Approximately 212 million Covid-19 vaccine doses have been administered in the US About 40% of the US population, more than 132 million people, have received at least one dose of vaccine... Apr 20
	Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from FDA Johnson's vaccine is indicated for individuals above 18 years... Mar 01
	Janssen received U.S. FDA approval for DARZALEX FASPRO Genmab announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (... Jan 16
	Johnson and Johnson vaccine trial shows immune response with few side effects FDA says J&J vaccine seems to be effective against covid... Jan 14
	ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ... Dec 21
	COVAX announces additional deals to access promising COVID-19 vaccine candidates COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply becomes available... Dec 19
	COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 COVAX, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating ... Dec 19
	Strides Pharma receives USFDA approval for Oxybutynin Chloride Tablets The medication is used to treat overactive bladder and urinary conditions... Dec 18
	Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate Janssen will aim to enroll participants in Belgium, Colombia, France, Germany, the Philippines, South Africa, Spain, the United Kingdom and the United States... Nov 30
	Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen Since 2015 Insilico Medicine pioneered the field of generative adversarial networks and reinforcement learning for generative chemistry and generative biology... Nov 10
	Tempus announces strategic collaboration with Janssen This collaboration will help both the companies utilize their respective strengths to improve patient care... Nov 03
	Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults ... Nov 02
	Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults ... Nov 02
25 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Wysa's mental health platform raises $20 million

HealthQuad Fund-II round closes at $162 million

Remix Therapeutics enters collaboration with Janssen to advance small molecule therapeutics

Reduced Risk of Long Covid Infection After Vaccination

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

Moderna's vaccine is the most effective, but Pfizer and J&J also protect well, CDC

Johnson & Johnson booster shot prompts large increase in immune response, company says

J&J Covid-19 vaccine lasts at least 8 months, protects against Delta variant, studies find

Risk of dying from Covid-19 40 times the risk of rare blood clot after receiving J&J vaccine

WHO authorizes China's Sinopharm Covid-19 vaccine for emergency use

FDA and CDC lift recommend â€œPauseâ€ on Johnson & Johnson Janssen COVID 19 vaccine

CDC, FDA deregulates Johnson & Johnson covid vaccine with blood clot warning

US COVID News Update: Approximately 212 million Covid-19 vaccine doses have been administered in the US

Johnson & Johnson's Covid-19 vaccine gets emergency use authorization from FDA

Janssen received U.S. FDA approval for DARZALEX FASPRO

Johnson and Johnson vaccine trial shows immune response with few side effects

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

COVAX announces additional deals to access promising COVID-19 vaccine candidates

COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021

Strides Pharma receives USFDA approval for Oxybutynin Chloride Tablets

Johnson & Johnson initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

Tempus announces strategic collaboration with Janssen

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

Trending Now

FDA and CDC lift recommend â€œPauseâ€ on Johnson & Johnson Janssen COVID 19 vaccine